Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Shylendra B Sreenivasappa, MD, R. Catchatourian, MD, Barbara Yim, Pharm.D

Blood (2008) 112 (11): 4546.

https://doi.org/10.1182/blood.V112.11.4546.4546

Published: 2008

Journal Articles

Benzocaine Induced Methemoglobinemia a Potentially Life Threatening Complication after Transesophageal Echocardiogram

Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm.D, R. Catchatourian, MD

Blood (2008) 112 (11): 4825.

https://doi.org/10.1182/blood.V112.11.4825.4825

Published: 2008

Journal Articles

Response of Hodgkin Lymphoma Patients of Different Ethnic Groups to Standard ABVD with or without Involved Field RT.

Samuel Ofori-Ntow, MD, Bety Ciobanu, MD, Margaret Clare Telfer, MD, Sunita Nathan, MD, Paula Kovarik, MD, Rafid Kouz, MD, Decebal S. Griza, MD, Thomas Lad, MD, R. Catchatourian, MD

Blood (2007) 110 (11): 4444.

https://doi.org/10.1182/blood.V110.11.4444.4444

Published: 2007

Journal Articles

Imatinib Treatment Experience in a Public Health System, Minority Patient Population with Chronic Myelogenous Leukemia (CML).

Sunita Nathan, MD, Shylendra Sreenivasappa, MD, Luciano Fochesatto Filho, MD, Decebal S. Griza, MD, Tracy Smiley, RN, Samuel Ofori-Ntow, MD, Margaret C. Telfer, MD, R. Catchatourian, MD

Blood (2007) 110 (11): 4576.

https://doi.org/10.1182/blood.V110.11.4576.4576

Published: 2007

Journal Articles

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Anshul Bamrolia, MD, Ahmad Jajeh, MD, R. Catchatourian, MD, David Osafo, MD, Deimante Tamkus, MD, Neelesh Sharma, MD, Ghassan Zalzaleh, MD, Sunita Nathan, MD, Perry Menini, MD

Blood (2006) 108 (11): 5105.

https://doi.org/10.1182/blood.V108.11.5105.5105

Published: 2006

Journal Articles

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

Sunita Nathan, MD, Olusola Ogundipe, MD, Perry Menini, DO, Anshul Bamrolia, MD, Decebal S. Griza, MD, Tracy Smiley, RN, Bhuvaneswari Subramanian, MD, Ahmad Jajeh, MD, Margaret Clare Telfer, MD, R. Catchatourian, MD

Blood (2006) 108 (11): 4956.

https://doi.org/10.1182/blood.V108.11.4956.4956

Published: 2006

NARROW

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Benzocaine Induced Methemoglobinemia a Potentially Life Threatening Complication after Transesophageal Echocardiogram

Response of Hodgkin Lymphoma Patients of Different Ethnic Groups to Standard ABVD with or without Involved Field RT.

Imatinib Treatment Experience in a Public Health System, Minority Patient Population with Chronic Myelogenous Leukemia (CML).

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Benzocaine Induced Methemoglobinemia a Potentially Life Threatening Complication after Transesophageal Echocardiogram

Response of Hodgkin Lymphoma Patients of Different Ethnic Groups to Standard ABVD with or without Involved Field RT.

Imatinib Treatment Experience in a Public Health System, Minority Patient Population with Chronic Myelogenous Leukemia (CML).

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only